Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 6—June 2005
Perspective

An Emptying Quiver: Antimicrobial Drugs and Resistance

J. Todd Weber*Comments to Author  and Patrice Courvalin†
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Institut Pasteur, Paris, France

Main Article

Figure 2

J. Todd Weber Dr. Weber is the director of the Office of Antimicrobial Resistance, National Center for Infectious Diseases, Centers for Disease Control and Prevention. He is responsible for coordinating antimicrobial resistance activities at CDC and co-chairs the federal Interagency Task Force on Antimicrobial Resistance. He works with other agencies, state governments, medical societies, and other public and private organizations to enhance antimicrobial resistance prevention and control, surve

Figure 2. J. Todd Weber Dr. Weber is the director of the Office of Antimicrobial Resistance, National Center for Infectious Diseases, Centers for Disease Control and Prevention. He is responsible for coordinating antimicrobial resistance activities at CDC and co-chairs the federal Interagency Task Force on Antimicrobial Resistance. He works with other agencies, state governments, medical societies, and other public and private organizations to enhance antimicrobial resistance prevention and control, surveillance and response, applied research, and training.

Main Article

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external